glutamine and Venous Thrombosis

glutamine has been researched along with Venous Thrombosis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's4 (57.14)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baskaran, S; Biswas, L; Biswas, R; Mohan, CG; Nair, S; Oommen, AT; Prakash, O; Sivasundar, S1
Jacob, D; Loew, A; Neuhaus, P; Riess, H1
Direskeneli, H; Saruhan-Direskeneli, G1
Alonso, J; Bosch, J; Córdoba, J; García-Pagán, JC; Mínguez, B; Rovira, A; Turnes, J1
Chen, CY; Cooley, BC; Schmeling, G1
Carrasco, F; Gomez-Parra, M; Herrerias, JM; Jimenez-Saenz, M; Piñar, A; Rebollo, J; Saenz, R1
Chi, HS; Kim, SB; Kim, SH; Kim, SW; Kim, TW; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Seo, EJ; Suh, C1

Other Studies

7 other study(ies) available for glutamine and Venous Thrombosis

ArticleYear
Molecular defect of 'Prothrombin Amrita': substitution of arginine by glutamine (Arg553 to Gln) near the Na(+) binding loop of prothrombin.
    Blood cells, molecules & diseases, 2013, Volume: 50, Issue:3

    Topics: Amino Acid Substitution; Arginine; Glutamine; Heterozygote; Humans; Male; Middle Aged; Mutation; Protein Binding; Prothrombin; Sodium; Venous Thrombosis

2013
Resistance to activated protein C caused by factor V Leiden mutation and orthotopic liver transplantation.
    Transplantation, 2005, May-27, Volume: 79, Issue:10

    Topics: Activated Protein C Resistance; Adult; Aged; Factor V; Female; Gene Frequency; Glutamine; Heterozygote; Humans; Incidence; Liver Transplantation; Male; Medical Records; Middle Aged; Mutation; Risk Factors; Survival Analysis; Thromboembolism; Venous Thrombosis

2005
R92Q TNFRSF1A mutation and Behçet's disease: comment on the article by Amoura et al.
    Arthritis and rheumatism, 2005, Volume: 52, Issue:8

    Topics: Arginine; Behcet Syndrome; Glutamine; Humans; Mutation; Receptors, Tumor Necrosis Factor, Type I; Venous Thrombosis

2005
Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.
    Hepatology (Baltimore, Md.), 2006, Volume: 43, Issue:4

    Topics: Administration, Oral; Adult; Ammonia; Attention; Body Water; Brain; Case-Control Studies; Female; Glutamine; Hepatic Encephalopathy; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Portal Vein; Venous Thrombosis

2006
Increased venous versus arterial thrombosis in the Factor V Leiden mouse.
    Thrombosis research, 2007, Volume: 119, Issue:6

    Topics: Amino Acid Substitution; Animals; Arginine; Arterial Occlusive Diseases; Arteries; Chlorides; Disease Models, Animal; Factor V; Ferric Compounds; Gene Frequency; Glutamine; Homozygote; Mice; Mice, Inbred C57BL; Mutation; Thrombosis; Venous Thrombosis

2007
Portal and mesenteric vein thrombosis in a patient heterozygous for a mutation (Arg506-->Gln) in the factor V gen (factor V Leiden).
    Journal of clinical gastroenterology, 1998, Volume: 27, Issue:4

    Topics: Adult; Arginine; Diagnosis, Differential; Factor V; Glutamine; Humans; Loss of Heterozygosity; Male; Mesenteric Veins; Portal Vein; Venous Thrombosis

1998
Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
    Journal of Korean medical science, 1998, Volume: 13, Issue:6

    Topics: Activated Protein C Resistance; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Arginine; Factor V; Glutamine; Humans; Korea; Middle Aged; Point Mutation; Prevalence; Venous Thrombosis

1998